$cbdMD(YCBD.US)$
cbdMD Announces Publication of Human Clinical Trial Data
cbdMD (NYSE: YCBD) announced the publication of its human clinical trial data in the Journal of the International Society of Sports Nutrition. The study, conducted by the University of South Carolina, evaluated the effects of daily intake of 100 mg of cbdMD's Broad Spectrum CBD blend over 12 weeks on healthy adults.
Key findings include significant pain reduction, improved psychological well-being in male participants,...

$cbdMD(YCBD.US)$
cbdMD Unveils ATRx Labs Premium Mushroom Line at GNC, Expanding cbdMD's Natural Wellness Solutions
cbdMD (NYSE American: YCBD) has launched the ATRx Labs Premium Mushroom Line exclusively at GNC stores nationwide. The line consists of four products targeting various health needs: Energy & Stamina, Memory & Cognition, Digestion & Microbiome, and Immune Support. Each supplement merges powerful mushroom extracts with clinically studied ingredients to support natural wellness. ...

$cbdMD(YCBD.US)$
LEGALIZATION UPDATE
Schumer And Other Democratic Senators File Bill To Federally Legalize Marijuana

$cbdMD(YCBD.US)$Watch Live: Schumer And Other Democratic Senators File Bill To Federally Legalize Marijuana

$cbdMD(YCBD.US)$
On Potential Reclassification of Marijuana
“The DEA’s proposal, which still must be reviewed by the White House Office of Management and Budget, would recognize the medical uses of cannabis and acknowledge it has less potential for abuse than some of the nation’s most dangerous drugs. However, it would not legalize marijuana outright for recreational use.”
“The expected recommendation will be reviewed by the White House Office of Management and Budget and undergo a public comme...